Real-world study of upfront genomic testing utilization in newly diagnosed non–small cell lung cancer.
221 Background: Comprehensive genomic profiling via tissue DNA next generation sequencing (NGS) is crucial for guiding precision medicine in both metastatic and early-stage non-small cell lung cancer (NSCLC). Complementary tests including liquid biopsy (LB) and tissue RNA sequencing may improve detection of act...